Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are ...
Per an HFSA news release, in the United States, it is estimated that heart failure prevalence may increase to 11.4 million by 2050.
From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for ...
Recently, scientists at Stanford University began to wonder why identical lab mice, bred with the same DNA and brought up in ...
According to data from the U.S. Centers for Disease Control and Prevention, deaths caused by alcohol use in the U.S. spiked during the pandemic, with over 49,000 in 2020. The height of the pandemic ...
If you have had a severe Covid infection, Dr. Goff said, you can reduce your risk of heart disease by eating a healthy diet, ...
Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...
Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...
CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...
A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...
Pharmacists who received active feedback about their heart failure patients increased the frequency of their patient interactions and prescribed more heart failure medication adjustments, according to ...
There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback